Skip to content
Screener

Assembly Biosciences ASMB Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
$42.79M-3.7%
ALN
Alnylam PharmaceuticalsALNY
$183.36M-4.7%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$983.41K+36.8%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$59.39M-8.4%
Absci Corporation logo
Absci CorporationABSI
$2.44M-29.4%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
10.1%-0.6pp

Other financials

Income statement

See full
Revenue$8.2M-12.8%
Operating income-$11.4M-14.4%
Net income-$9.1M-3.0%
EPS (diluted)-$0.54+53.8%

Balance sheet

See full
Cash & equivalents$31.1M+32.9%
Total debt$2.5M-17.5%
Total equity$198.6M+632%
Total assets$235.5M+138%

Cash flow

See full
Operating cash flow-$22.1M+5.7%
CapEx$19.0K
Free cash flow-$22.1M+5.6%

Valuation

See full
Market cap$529.91M+193%
Enterprise value$501.28M+213%
P/S7.5×+2.0×

Profitability

See full
Operating margin-116.8%-26.1pp
Net margin-103.6%-22.7pp
FCF margin-150%-231pp

Returns & leverage

See full
Return on equity-36.9%-15.1pp
Debt / equity-0.1×
Current ratio6.6×+4.6×

Where this comes from

Reported directly by Assembly Biosciences in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Assembly Biosciences’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:17 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211987
Line itemMarch 31, 2026December 31, 2025
Prepaid expenses and other current assets5,5615,469
Total current assets232,613254,549
Property and equipment, net214221
Operating lease right-of-use (ROU) assets2,3692,508
Other assets312312
Total assets$235,508$257,590
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities

Item 1. Financial Statements

FAQ

What is Assembly Biosciences's operating lease ROU assets?
Assembly Biosciences (ASMB) reported operating lease ROU assets of $2.37M in Q1 2026.
How has Assembly Biosciences's operating lease ROU assets changed year-over-year?
Assembly Biosciences's operating lease ROU assets decreased by 19.1% year-over-year, from $2.93M to $2.37M.
What is the long-term trend for Assembly Biosciences's operating lease ROU assets?
Over 5 years (2020 to 2025), Assembly Biosciences's operating lease ROU assets has grown at a -22.8% compound annual growth rate (CAGR), from $9.13M to $2.51M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Assembly Biosciences's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude